Cystic Kidney Disease: An Early Manifestation of a Rare Syndrome
DOI:
https://doi.org/10.71749/pkj.32Palavras-chave:
Child, Chromosomes, Human, Pair 17, Kidney Diseases, Cystic, PyelectasisResumo
Pediatric cystic kidney diseases include a diversity of hereditary or non‐hereditary conditions, whose phenotypic presen‐ tation can vary from asymptomatic to end‐stage renal disease. We report a case of a male with a prenatal diagnosis of pyelectasis. Throughout the first two years of life, serial renal ultrasound showed regression of pyelectasis, but increased renal echogenicity, first identified at three months‐old. The family history of renal diseases was negative. Voiding cystourethrography showed no signs of vesicoureteral reflux and the MAG3 renogram revealed equally functioning kidneys. At 29 months‐old, elevated transaminases and two cortical cysts were detected, raising the suspicion of a cystic kidney disease. A hepatic biopsy showed no signs of fibrosis. He was tested for autosomal recessive polycystic kidney disease (ARPKD), which was negative. Renal ultrasound showed an increase in the number of cysts bilaterally, with diffuse hyperechogenicity and reduction of parenchymal‐sinus differ‐ entiation. Throughout the years, he maintained normal blood pressure and elevated transaminases, with rising serum creatinine from the age of 13 years. A NGS panel for cystic diseases detected 17q12 deletion syndrome, which causes renal cysts and other urinary tract malfunctions, and may also present with mature‐onset diabetes of the young type 5 (MODY5) diabetes, hyperparathyroidism, altered hepatic function and behavioral and psychiatric conditions. On the last appointment (15 years‐old), ultrasound showed bilateral cysts (10 mm), worsened renal function (glomerular filtration rate (GFR) of 71 mL/min/1.73 m2), hypomagnesemia under treatment, and normal transaminases and glycemia. In this case, an atypical presentation of cystic kidney disease led to an extended investigation resourcing to other genetic panels, allowing the etiological diagnosis and enabling the early identification and monitorization of possible extra‐renal comorbidities commonly associated with this syndrome.Downloads
Referências
Kwatra S, Krishnappa V, Mhanna C, Murray T, Novak R, Sethi SK, et al. Cystic diseases of childhood: a review. Urology. 2017;110:184‐91. doi: 10.1016/j.urology.2017.07.040.
Ferro F, Vezzali N, Comploj E, Pedron E, Di Serafino M, Esposito F, et al. Pediatric cystic diseases of the kidney. J Ultrasound. 2019;22:381‐93. doi: 10.1007/s40477‐018‐0347‐9.
De Groof J, Dachy A, Breysem L, Mekahli D. Cystic kidney diseases in children. Arch Pediatr. 2023;30:240‐6. doi: 10.1016/j. arcped.2023.02.005.
Rasmussen M, Vestergaard EM, Graakjaer J, Petkov Y, Bache I, Fagerberg C, et al. 17q12 deletion and duplication syndrome in Denmark‐A clinical cohort of 38 patients and review of the literature. Am J Med Genet A. 2016;170:2934‐42. doi: 10.1002/ajmg.a.37848.
El‐Khairi R, Vallier L. The role of hepatocyte nuclear factor 1β in disease and development. Diabetes Obes Metab. 2016;18 Suppl 1:23‐32. doi: 10.1111/dom.12715.
Mitchel MW, Moreno‐De‐Luca D, Myers SM, Levy RV, Turner S, Ledbetter DH, et al. 17q12 Recurrent Deletion Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al, editors. GeneReviews(®). Seattle: University of Washington; 1993
Chen YZ, Gao Q, Zhao XZ, Chen YZ, Bennett CL, Xiong XS, et al. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chin Med J. 2010;123:3326‐33.
Kotalova R, Dusatkova P, Cinek O, Dusatkova L, Dedic T, Seeman T, et al. Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review. World J Gastroenterol. 2015;21:2550‐7. doi: 10.3748/wjg.v21.i8.2550.
Nakamura M, Kanda S, Kajiho Y, Morisada N, Iijima K, Harita Y. A case of 17q12 deletion syndrome that presented antenatally with markedly enlarged kidneys and clinically mimicked autosomal recessive polycystic kidney disease. CEN Case Rep. 2021;10:543‐8.
Dubois‐Laforgue D, Cornu E, Saint‐Martin C, Coste J, Bellanné‐Chantelot C, Timsit J. Diabetes, associated clinical spectrum, long‐term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Care. 2017;40:1436‐43. doi: 10.2337/dc16‐2462.
Pinon M, Carboni M, Colavito D, Cisarò F, Peruzzi L, Pizzol A, et al. Not only Alagille syndrome. Syndromic paucity of interlobular bile ducts secondary to HNF1β deficiency: a case report and literature review. Ital J Pediatr. 2019;45:27. doi: 10.1186/s13052‐019‐0617‐y.
Moreno‐De‐Luca D, Mulle JG, Kaminsky EB, Sanders SJ, Myers SM, Adam MP, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010;87:618‐30. doi: 10.1016/j.ajhg.2010.10.004.
Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R, et al. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet. 2007;81:1057‐69. doi: 10.1086/522591.
Ferrè S, Bongers EM, Sonneveld R, Cornelissen EA, van der Vlag J, van Boekel GA, et al. Early development of hyperparathyroidism due to loss of PTH transcriptional repression in patients with HNF1β mutations? J Clin Endocrinol Metab. 2013;98:4089‐96. doi: 10.1210/jc.2012‐3453.
Kołbuc M, Leßmeier L, Salamon‐Słowińska D, Małecka I, Pawlaczyk K, Walkowiak J, et al. Hypomagnesemia is underestimated in children with HNF1B mutations. Pediatr Nephrol. 2020;35:1877‐86. doi: 10.1007/s00467‐020‐04576‐6.
Downloads
Publicado
Edição
Secção
Licença
Direitos de Autor (c) 2024 Catarina Leuzinger-Dias, Joana P. Ramos, Marta Machado, Carolina Cordinhã, Carmen do Carmo, Clara Gomes (Author)
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial 4.0.
